Rapamune 1 mg, überzogene Tabletten - 100 Tablette(n) Swissmedic Key 55804003 Registration Holder Pfizer AG Name Rapamune 1 mg, überzogene Tabletten Date of registration 14.12.2001 Introduction of Sequence 14.12.2001 ATC-Classification Sirolimus (L04AA10) Revision date 19.06.2006 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size 100 Tablette(n) Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 392.93 Limitation No Deductible 10 % Consumer price 443.75 Feedback FB Daily cost GTIN 7680558040036 Medication Code Biotechnologika Pharmacode 2474156 Disponibility
Composition sirolimusum 1 mg, poloxamerum 188, lactosum monohydricum 86.4 mg, macrogolum 8000, magnesii stearas, talcum, macrogolum 20'000, glyceroli mono-oleas, lacca, calcii sulfas anhydricus, cellulosum microcristallinum, saccharum 213.85 mg, E 171, povidonum K 29-32, int-rac-alpha-tocopherylis acetas, cera carnauba, Drucktinte: lacca, E 172 (rubrum), propylenglycolum, simeticonum, pro compresso obducto. Packungsbestandteile Galenic Form überzogene Tabletten Active Agent Dose Sirolimus 1 mg
BAG: Active Agent Dose Sirolimus 1 mg
Inactive agents Dose additional_information (Rubrum) Calcii Sulfas Anhydricus Cellulosum Microcristallinum Cera Carnauba E 171 color. E 172 color. Glyceroli Mono-Oleas Int-Rac-Alpha-Tocopherylis Acetas Lacca Drucktinte Lactose Monohydrate 86.4 mg Macrogol 20000 Magnesii Stearas Poloxamer 188 Povidonum K 29-32 Pro Compresso Obducto Propylenglycol Saccharum 213.85 mg Simeticone Talcum
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
